Document is current
Any future updates will be listed below
-
Authors
González-Álamos, María https://orcid.org/0000-0002-5769-4299
Torres, Manuel https://orcid.org/0009-0004-0471-8826
Bartolomé, Blanca https://orcid.org/0000-0001-5423-9939
Vivanco, Luis https://orcid.org/0000-0003-3747-6240
-
Funding
Funding for this research was provided by:
Interreg (EFA060/01-CO-BIEN)
- License Information
-
More Information
Article History
Received: 9 January 2026
Accepted: 14 May 2026
First Online: 20 May 2026
Declarations
:
: The study received approval from the Ethics Committee for Research with Medicines of the Autonomous Community of La Rioja (Comité de Ética en Investigación con Medicamentos de La Rioja; Ref. CEImLAR PI-795). CEImLAR is the ethics committee responsible for the ethical evaluation of all studies involving human subjects conducted in La Rioja, Spain. Written informed consent was obtained from all participants prior to their participation, in accordance with Real Decreto 1090/2015 (Spain) and the principles of the Declaration of Helsinki. Furthermore, all participants were informed that they could withdraw from the study at any time.
: No applicable.
: The authors declare no competing interests.
